SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,592.45 -318.56
( -0.39%)

Global Indices

Nasdaq

52,431.30 -76.19
(-0.15%)

Dow Jones

7,621.14 -19.24
(-0.25%)

Hang Seng

61,109.24 289.88
(0.48%)

Nikkei 225

10,863.06 27.59
(0.25%)

Forex

USD-INR

93.72 0.15
(0.16%)

EUR-INR

104.27 -0.51
(-0.49%)

GBP-INR

124.72 -0.66
(-0.52%)

JPY-INR

0.59 0.00
(-0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Reliance Industries Ltd

Industry : Refineries

BSE Code

ISIN Demat

Book Value()

500325

INE002A01018

433.7077533

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

RELIANCE

39.73

1805375.49

EPS(TTM)

Face Value()

Div & Yield %

33.58

0.45

Back

urja global ltd

Sun Pharmaceutical Industries consolidated net profit declines 36.22% in the September 2026 quarter

Oct 30,2026

Net profit of Sun Pharmaceutical Industries declined 36.22% to Rs 1988.53 crore in the quarter ended September 2026 as against Rs 3117.95 crore during the previous quarter ended September 2025. Sales rose 11.77% to Rs 16100.01 crore in the quarter ended September 2026 as against Rs 14405.22 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	16100.01	14405.22	12
OPM %	29.47	31.43	-
PBDT	5186.54	4897.11	6
PBT	4428.20	4167.61	6
NP	1988.53	3117.95	-36

81,592.45 -318.56 ( -0.39%)

52,431.30 -76.19 (-0.15%)

7,621.14 -19.24 (-0.25%)

61,109.24 289.88 (0.48%)

10,863.06 27.59 (0.25%)

93.72 0.15 (0.16%)

104.27 -0.51 (-0.49%)

124.72 -0.66 (-0.52%)

0.59 0.00 (-0.43%)